SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-17-340988
Filing Date
2017-11-13
Accepted
2017-11-13 16:37:04
Documents
2
Group Members
KEVIN FERROVATERA HEALTHCARE PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d483368dsc13d.htm SC 13D 80925
2 EX-99.1 d483368dex991.htm EX-99.1 6279
  Complete submission text file 0001193125-17-340988.txt   88973
Mailing Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149 919-576-2306
MELINTA THERAPEUTICS, INC. /NEW/ (Subject) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86624 | Film No.: 171196487
SIC: 2834 Pharmaceutical Preparations

Mailing Address 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022
Business Address 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022 212-590-2950
VATERA HOLDINGS LLC (Filed by) CIK: 0001548880 (see all company filings)

IRS No.: 208894647 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D